Log in to your Inderes Free account to see all free content on this page.
AcuCort
0.59 SEK
-1.01 %
Less than 1K followers
ACUC
Spotlight Stock Market
Biotechnology & Pharmaceuticals
Health Care
Overview
Financials & Estimates
Ownership
Investor consensus
-1.01 %
+1.90 %
-0.84 %
-35.20 %
-7.80 %
+0.41 %
-54.54 %
-83.34 %
-76.85 %
AcuCort is a pharmaceutical company. The company develops and commercializes pharmaceuticals based on well-established substances with a focus on user-friendliness and ease of administration. The company's leading product is an oral film for the acute treatment of allergic reactions and other conditions with high medical demand. Products are aimed at patients and caregivers globally. AcuCort was founded in 2006 and is headquartered in Lund, Sweden.
Read moreMarket cap
138.56M SEK
Turnover
47.05K SEK
Revenue
EBIT %
P/E
Dividend yield-%
Revenue and EBIT-%
Revenue K
EBIT-% (adj.)
EPS and dividend
EPS (adj.)
Dividend %
Financial calendar
20.2.
2026
Annual report '25
All
Press releases
ShowingAll content types
AcuCort AB: AcuCort strengthens its management team with the appointment of Anna Chérouvrier Hansson as Business Development Director
AcuCort AB: AcuCort granted extended SME status by the European Medicines Agency (EMA)
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio